NCT05918029View on ClinicalTrials.gov

Bone in CKD Alkali Response (BICARb Pilot Trial)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Chronic Kidney DiseasesBone Loss
Interventions
DRUG

Potassium Citrate Extended Release Oral Tablet

Oral potassium citrate extended-release tablet

OTHER

Placebo

Placebo capsule identical to active ingredient

DRUG

Potassium Citrate and Citric Acid Oral Solution

Oral potassium citrate and citric acid

Trial Locations (2)

10461

RECRUITING

Albert Einstein College of Medicine, The Bronx

15213

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

University of Utah

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Albert Einstein College of Medicine

OTHER